These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 26363151)

  • 1. Interleukin-33 is released in spinal cord and suppresses experimental autoimmune encephalomyelitis in mice.
    Chen H; Sun Y; Lai L; Wu H; Xiao Y; Ming B; Gao M; Zou H; Xiong P; Xu Y; Tan Z; Gong F; Zheng F
    Neuroscience; 2015 Nov; 308():157-68. PubMed ID: 26363151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Li M; Li Y; Liu X; Gao X; Wang Y
    J Neuroimmunol; 2012 Jun; 247(1-2):25-31. PubMed ID: 22516472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells.
    Xiao Y; Lai L; Chen H; Shi J; Zeng F; Li J; Feng H; Mao J; Zhang F; Wu N; Xu Y; Tan Z; Gong F; Zheng F
    Mol Immunol; 2018 Sep; 101():550-563. PubMed ID: 30173119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active secretion of IL-33 from astrocytes is dependent on TMED10 and promotes central nervous system homeostasis.
    Jiao M; Wang C; Tang X; Dai C; Zhang N; Fan A; Qian Z; Liu S; Zhang F; Li B; Xu Y; Tan Z; Gong F; Lu Y; Zheng F
    Brain Behav Immun; 2024 Jul; 119():539-553. PubMed ID: 38663774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huperzine A inhibits CCL2 production in experimental autoimmune encephalomyelitis mice and in cultured astrocyte.
    Tian GX; Zhu XQ; Chen Y; Wu GC; Wang J
    Int J Immunopathol Pharmacol; 2013; 26(3):757-64. PubMed ID: 24067473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
    Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
    Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
    Hu X; Qin X
    Int J Mol Med; 2013 May; 31(5):1209-21. PubMed ID: 23525227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
    Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
    J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
    Yun J; Gu SM; Yun HM; Son DJ; Park MH; Lee MS; Hong JT
    Oncotarget; 2015 Dec; 6(38):40452-63. PubMed ID: 26564962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
    Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
    Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
    Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
    Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
    Zhao X; Zhang X; Lv Y; Xu Y; Li M; Pan Q; Chu Y; Liu N; Zhang GX; Zhu L
    Immunol Lett; 2016 Oct; 178():97-104. PubMed ID: 27562326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
    Bhopale MK; Hilliard B; Constantinescu CS; Fujioka T; Ventura E; Phillips SM; Rostami A
    Exp Mol Pathol; 2014 Feb; 96(1):108-17. PubMed ID: 23872438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.
    Kamizato K; Sato S; Shil SK; Umaru BA; Kagawa Y; Yamamoto Y; Ogata M; Yasumoto Y; Okuyama Y; Ishii N; Owada Y; Miyazaki H
    Neuroscience; 2019 Jun; 409():120-129. PubMed ID: 31051217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.
    Pomeshchik Y; Kidin I; Korhonen P; Savchenko E; Jaronen M; Lehtonen S; Wojciechowski S; Kanninen K; Koistinaho J; Malm T
    Brain Behav Immun; 2015 Feb; 44():68-81. PubMed ID: 25153903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic effect of anti-CD52 treatment in murine experimental autoimmune encephalomyelitis is associated with altered IL-33 and ST2 expression levels.
    Barbour M; Wood R; Hridi SU; Wilson C; McKay G; Bushell TJ; Jiang HR
    J Neuroimmunol; 2018 May; 318():87-96. PubMed ID: 29526407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
    Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
    J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.